Loewy Caroline M

CFO at PONIARD PHARMACEUTICALS, INC. · on record since Jun 18, 2007
Chief Financial Officer at CORCEPT THERAPEUTICS INC · on record since Dec 2, 2008
Director at CAL-BAY INTERNATIONAL INC · on record since Dec 8, 2016
Director at Aptose Biosciences Inc. · on record since Dec 21, 2018
Director at PhaseBio Pharmaceuticals Inc · on record since Oct 17, 2018
Director at ZOGENIX, INC. · on record since Sep 23, 2020
Director at eFFECTOR Therapeutics, Inc. · on record since Jan 14, 2021
Director at CERO THERAPEUTICS HOLDINGS, INC. · on record since Oct 12, 2021
Former Director at Aptose Biosciences Inc. · on record since Jun 15, 2022

Insider trading activity of Loewy Caroline M

Transactions on record: 62; since Jun 26, 2006

Open-market buys: 15; $109.8K

Open-market sells: 0

Companies traded: 8; last filing Jun 13, 2024

Figures computed from official regulatory filings — .

Companies where Loewy Caroline M has traded

eFFECTOR Therapeutics, Inc.4 tx · Jun 13, 2024
CAL-BAY INTERNATIONAL INC20 tx · Mar 22, 2024
CERO THERAPEUTICS HOLDINGS, INC.2 tx · Feb 16, 2024
PhaseBio Pharmaceuticals Inc6 tx · May 19, 2023
ZOGENIX, INC.4 tx · Mar 9, 2022
Aptose Biosciences Inc.5 tx · Jan 20, 2022
1 tx · $816K · Dec 2, 2008
20 tx · $960.6K · Mar 6, 2008

Track record of Loewy Caroline M

Statistical track record

Free account

Open-market buys: 15

Last buy: Mar 6, 2008

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of Loewy Caroline M

Co-insiders of Loewy Caroline M

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
eFFECTOR Therapeutics, Inc.Listing on record	Jun 13, 2024	AwardD (derivative)	800	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
CAL-BAY INTERNATIONAL INCListing on record	Mar 22, 2024	OtherD (derivative)	-30,000	—	n/a (No price was disclosed in the filing)	SEC
CAL-BAY INTERNATIONAL INCListing on record	Mar 22, 2024	OtherD (derivative)	-25,000	—	n/a (No price was disclosed in the filing)	SEC
CAL-BAY INTERNATIONAL INCListing on record	Mar 22, 2024	OtherD (derivative)	-15,000	—	n/a (No price was disclosed in the filing)	SEC
CAL-BAY INTERNATIONAL INCListing on record	Mar 22, 2024	OtherD (derivative)	-7,500	—	n/a (No price was disclosed in the filing)	SEC
CAL-BAY INTERNATIONAL INCListing on record	Mar 22, 2024	OtherD (derivative)	-67,000	—	n/a (No price was disclosed in the filing)	SEC
CAL-BAY INTERNATIONAL INCListing on record	Mar 22, 2024	OtherD (derivative)	-49,245	—	n/a (No price was disclosed in the filing)	SEC
CAL-BAY INTERNATIONAL INCListing on record	Mar 22, 2024	OtherD (derivative)	-27,705	—	n/a (No price was disclosed in the filing)	SEC
CAL-BAY INTERNATIONAL INCListing on record	Mar 22, 2024	OtherD (derivative)	-14,010	—	n/a (No price was disclosed in the filing)	SEC
CAL-BAY INTERNATIONAL INCListing on record	Mar 22, 2024	OtherD (derivative)	-32,000	—	n/a (No price was disclosed in the filing)	SEC
CAL-BAY INTERNATIONAL INCListing on record	Mar 22, 2024	OtherD (derivative)	-16,000	—	n/a (No price was disclosed in the filing)	SEC
eFFECTOR Therapeutics, Inc.Listing on record	Feb 21, 2024	AwardD (derivative)	2,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
CERO THERAPEUTICS HOLDINGS, INC.Listing on record	Feb 16, 2024	Other	5,828	—	n/a (No price was disclosed in the filing)	SEC
CAL-BAY INTERNATIONAL INCListing on record	Jan 26, 2024	AwardD (derivative)	14,010	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
eFFECTOR Therapeutics, Inc.Listing on record	Sep 11, 2023	AwardD (derivative)	40,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
PhaseBio Pharmaceuticals IncListing unverified	May 19, 2023	Exercise	3,750	—	n/a (No price was disclosed in the filing)	SEC
PhaseBio Pharmaceuticals IncListing unverified	May 19, 2023	ExerciseD (derivative)	-3,750	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
CAL-BAY INTERNATIONAL INCListing on record	Jan 27, 2023	AwardD (derivative)	25,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
ZOGENIX, INC.Listing unverified	Mar 9, 2022	OtherD (derivative)	-20,000	—	n/a (No price was disclosed in the filing)	SEC
ZOGENIX, INC.Listing unverified	Mar 9, 2022	OtherD (derivative)	-22,000	—	n/a (No price was disclosed in the filing)	SEC
CAL-BAY INTERNATIONAL INCListing on record	Jan 27, 2022	AwardD (derivative)	67,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Aptose Biosciences Inc.Listing unverified	Jan 20, 2022	AwardD (derivative)	50,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
CERO THERAPEUTICS HOLDINGS, INC.Listing on record	Oct 12, 2021	OtherD (derivative)	17,500	—	n/a (No price was disclosed in the filing)	SEC
PhaseBio Pharmaceuticals IncListing unverified	Jun 4, 2021	AwardD (derivative)	14,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
ZOGENIX, INC.Listing unverified	May 28, 2021	AwardD (derivative)	22,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
eFFECTOR Therapeutics, Inc.Listing on record	Jun 13, 2024	AwardD (derivative)	800	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
CAL-BAY INTERNATIONAL INCListing on record	Mar 22, 2024	OtherD (derivative)	-30,000	—	n/a (No price was disclosed in the filing)	SEC
CAL-BAY INTERNATIONAL INCListing on record	Mar 22, 2024	OtherD (derivative)	-25,000	—	n/a (No price was disclosed in the filing)	SEC
CAL-BAY INTERNATIONAL INCListing on record	Mar 22, 2024	OtherD (derivative)	-15,000	—	n/a (No price was disclosed in the filing)	SEC
CAL-BAY INTERNATIONAL INCListing on record	Mar 22, 2024	OtherD (derivative)	-7,500	—	n/a (No price was disclosed in the filing)	SEC
CAL-BAY INTERNATIONAL INCListing on record	Mar 22, 2024	OtherD (derivative)	-67,000	—	n/a (No price was disclosed in the filing)	SEC
CAL-BAY INTERNATIONAL INCListing on record	Mar 22, 2024	OtherD (derivative)	-49,245	—	n/a (No price was disclosed in the filing)	SEC
CAL-BAY INTERNATIONAL INCListing on record	Mar 22, 2024	OtherD (derivative)	-27,705	—	n/a (No price was disclosed in the filing)	SEC
CAL-BAY INTERNATIONAL INCListing on record	Mar 22, 2024	OtherD (derivative)	-14,010	—	n/a (No price was disclosed in the filing)	SEC
CAL-BAY INTERNATIONAL INCListing on record	Mar 22, 2024	OtherD (derivative)	-32,000	—	n/a (No price was disclosed in the filing)	SEC
CAL-BAY INTERNATIONAL INCListing on record	Mar 22, 2024	OtherD (derivative)	-16,000	—	n/a (No price was disclosed in the filing)	SEC
eFFECTOR Therapeutics, Inc.Listing on record	Feb 21, 2024	AwardD (derivative)	2,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
CERO THERAPEUTICS HOLDINGS, INC.Listing on record	Feb 16, 2024	Other	5,828	—	n/a (No price was disclosed in the filing)	SEC
CAL-BAY INTERNATIONAL INCListing on record	Jan 26, 2024	AwardD (derivative)	14,010	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
eFFECTOR Therapeutics, Inc.Listing on record	Sep 11, 2023	AwardD (derivative)	40,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
PhaseBio Pharmaceuticals IncListing unverified	May 19, 2023	Exercise	3,750	—	n/a (No price was disclosed in the filing)	SEC
PhaseBio Pharmaceuticals IncListing unverified	May 19, 2023	ExerciseD (derivative)	-3,750	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
CAL-BAY INTERNATIONAL INCListing on record	Jan 27, 2023	AwardD (derivative)	25,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
ZOGENIX, INC.Listing unverified	Mar 9, 2022	OtherD (derivative)	-20,000	—	n/a (No price was disclosed in the filing)	SEC
ZOGENIX, INC.Listing unverified	Mar 9, 2022	OtherD (derivative)	-22,000	—	n/a (No price was disclosed in the filing)	SEC
CAL-BAY INTERNATIONAL INCListing on record	Jan 27, 2022	AwardD (derivative)	67,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Aptose Biosciences Inc.Listing unverified	Jan 20, 2022	AwardD (derivative)	50,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
CERO THERAPEUTICS HOLDINGS, INC.Listing on record	Oct 12, 2021	OtherD (derivative)	17,500	—	n/a (No price was disclosed in the filing)	SEC
PhaseBio Pharmaceuticals IncListing unverified	Jun 4, 2021	AwardD (derivative)	14,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
ZOGENIX, INC.Listing unverified	May 28, 2021	AwardD (derivative)	22,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC